Home/Filings/4/A/0001104659-24-043288
4/A//SEC Filing

Herbert Timothy P. 4/A

Accession 0001104659-24-043288

CIK 0001609550other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 9:52 PM ET

Size

25.8 KB

Accession

0001104659-24-043288

Insider Transaction Report

Form 4/AAmended
Period: 2024-04-01
Herbert Timothy P.
DirectorCEO and President
Transactions
  • Sale

    Common Stock

    2024-04-01$203.33/sh9,388$1,908,86294,270 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$204.35/sh10,694$2,185,31983,576 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$205.27/sh11,645$2,390,36971,931 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$206.19/sh3,379$696,71668,552 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$207.25/sh1,420$294,29567,132 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$208.34/sh1,492$310,84365,640 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$209.46/sh1,310$274,39364,330 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$210.99/sh232$48,95064,098 total(indirect: By Trust)
  • Sale

    Common Stock

    2024-04-01$213.26/sh440$93,83463,658 total(indirect: By Trust)
Holdings
  • Common Stock

    9,690
  • Common Stock

    (indirect: By LLC)
    117,658
  • Common Stock

    (indirect: By Trust)
    115,731
Footnotes (12)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F11]Securities held by the TPH 2022 LLC.
  • [F12]Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
  • [F2]Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Inspire Medical Systems, Inc.

CIK 0001609550

Entity typeother

Related Parties

1
  • filerCIK 0001737136

Filing Metadata

Form type
4/A
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 9:52 PM ET
Size
25.8 KB